Clinical Trials Browser

Phase 2 × Neoplasm Metastasis × encorafenib × Clear all

NCT03898908 2025-05-21

EBRAIN-MEL

Phase 2 Completed

48 enrolled 24 charts

CNSDermatologic

Brain Neoplasms, Melanoma, Neoplasm Metastasis